BefejeződöttFázis nélkül
Investigation of the Safety and Effectiveness of a Trifocal IOL
A legfontosabb adatok
- Ki végzi
- Beaver-Visitec International, Inc.
- Hol
- Alexandria, Bloomington, Bozeman, Brecksville, Dallas, Indianapolis, Las Vegas, Lynchburg, Nacogdoches, Northridge, Omaha, Orange, Orland Park, Salt Lake City, San Antonio, Sioux Falls, St Louis, Vineland, West Fargo és West Mifflin (Egyesült Államok)Mind a 20 helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 539 fő vett részt
- Kezdés
- 2022. ápr. 28.
- Befejezés
- 2024. máj. 13.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- FINEVISION HP IOL
- Alcon AcrySof SN60AT
- A regiszteradat frissítve
- 2025. január 29.
Ki vehet részt
- Életkor
- 22 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Male or female adults, age 22 years or older at the Preoperative Visit
- Visually significant cataracts in both eyes that are eligible for phacoemulsification cataract surgery
- Willing to undergo cataract surgery in the second operative eye within 7 - 30 days after surgery in the first eye
- Projected Best Corrected Distance Visual Acuity (BCDVA) of 0.2 logMAR (20/32 Snellen) or better in each eye after cataract surgery/IOL implantation, as determined by the medical judgement of the Investigator
- Eligible for receipt of an IOL power within the range of the investigational IOL (+10.0 D to +30.0 D, in 0.50 D increments) in each eye
- Contact lens users must be willing to discontinue wear of their lenses in accordance with the following requirements:; Rigid gas permeable lenses for ≥ 7 days prior to the Preoperative Visit; Soft contact lenses for ≥ 3 days prior to the Preoperative Visit Contact lens wearers must demonstrate a stable refraction (within ±0.50 D for both sphere and cylinder) in each eye, as determined by manifest refraction on two consecutive examination dates at least one week apart after discontinuation of contact lens wear
- Provide signed written consent prior to participation in any study-related procedures
- Ability, comprehension, and willingness to follow study instructions, and likely to complete all study visits
- Female subjects must be 1-year postmenopausal, surgically sterilized, or, if of childbearing potential, have a negative urine pregnancy test at the Preoperative Visit. Women of childbearing potential must use an acceptable form of contraception throughout the study. Acceptable methods include at least one of the following: intrauterine (intrauterine device), hormonal (oral, injection, patch, implant, ring), barrier with spermicide (condom, diaphragm), or abstinence
Ki nem vehet részt
- Reasonably expected to require secondary ocular surgical intervention or laser treatment other than YAG capsulotomy in either eye during the study participation period
- Previous intraocular, corneal, or retinal detachment surgery, including corneal transplant, LASIK, astigmatic keratotomy and limbal relaxing incisions in either eye
- Clinically significant ocular inflammation or infection present ≤ 30 days in either eye prior to the Preoperative Visit
- Use of medications known to interfere with visual performance, pupil dilation, or iris structure ≤ 30 days prior to the Preoperative Visit
- Participation in any study of an investigational, interventional product within 30 days prior to the Preoperative Visit or at any time during the study period
- History or presence of, or predisposition to, degenerative visual disorders (e.g., macular degeneration, retinal detachment, proliferative diabetic retinopathy, or other retinal disorders) predicted to result in BCDVA worse than 0.2 LogMAR (20/32 Snellen) in either eye during the study participation period
- Significant anterior segment pathology in either eye that might increase intraoperative risk or compromise IOL stability (e.g., pseudoexfoliation syndrome)
- Presence or history of one or more severe/serious ocular conditions (e.g., glaucoma, uveitis, ocular infection, severe dry eye) in either eye, or any other unstable medical condition (e.g., uncontrolled diabetes) that in the opinion of the Investigator would put the subject's health at risk, confound the results of the study and/or prevent the subject from completing all study visits
- Presence of one or more clinically significant corneal abnormalities in either eye, including corneal dystrophy, irregularity, or edema per the Investigator's medical opinion
- Rubella, congenital, traumatic or complicated cataract in either eye
- Preoperative keratometric astigmatism > 1.0 D or irregular corneal astigmatism in either eye (Note: corneal incisions intended to reduce astigmatism are not permitted)
- Pregnant or nursing females
Helyszínek itt: Egyesült Államok
- Vance Thompson Vision, MN SiteAlexandria, Egyesült Államok
- Chu Vision InstituteBloomington, Egyesült Államok
- Vance Thompson Vision, MT SiteBozeman, Egyesült Államok
- Cleveland Eye ClinicBrecksville, Egyesült Államok
- Key-Whitman Eye CenterDallas, Egyesült Államok
- Michael Washburn Center for Ophthalmic ResearchIndianapolis, Egyesült Államok
- Center for SightLas Vegas, Egyesült Államok
- Piedmont Eye CenterLynchburg, Egyesült Államok
- Lehmann Eye CenterNacogdoches, Egyesült Államok
- Mitchell C Shultz MD/Shultz Chang VisionNorthridge, Egyesült Államok
- Vance Thompson Vision NE SiteOmaha, Egyesült Államok
- Coastal Vision Medical GroupOrange, Egyesült Államok
- Arbor Centers for Eye CareOrland Park, Egyesült Államok
- The Eye Institute of UtahSalt Lake City, Egyesült Államok
- Parkhurst NuVisionSan Antonio, Egyesült Államok
- Vance Thompson Vision. SD SiteSioux Falls, Egyesült Államok
- Ophthalmology Consultants LtdSt Louis, Egyesült Államok
- Eye Associates & SurgiCenterVineland, Egyesült Államok
- Vance Thompson Vision ND SiteWest Fargo, Egyesült Államok
- Associates in Ophthalmology LtdWest Mifflin, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study is a prospective, multicenter, randomized, double masked confirmatory trial comparing an investigational trifocal intraocular lens (IOL) and a commercially available monofocal IOL.
A vizsgálat 2 csoportja
- FINEVISION HPA vizsgált kezelés
Trifocal FINEVISION HP. Cataractous lens will be removed in the study eyes and the FINEVISION HP will be implanted in the capsular bag.
Kezelés: FINEVISION HP IOL
- Control ProductMár használt kezelés, összehasonlításként
Cataractous lens will be removed in the study eyes and the Alcon AcrySof® SN60AT IOL will be implanted in the capsular bag.
Kezelés: Alcon AcrySof SN60AT
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Clinical Investigation of the Safety and Effectiveness of FINEVISION HP Trifocal IOL
- A regiszteradat frissítve
- 2025. január 29.